Climacteric + Menopause Flashcards

1
Q

The menopause is the end of the female reproductive life. It is a physiological process which begins as perimenopause (climacteric) at around the age of 45 and progresses until the final menarche and the end of fertility (UK average age is 51).

What is the recommendation for how long to be using effective contraception in menopausal women?

A
  • 12 months after the last period in women > 50 years
  • 24 months after last period in women < 50 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What hormonal changes occur during menopause?

A
  • reduction in circulating oestrogen
  • due to reduced sensitivity of ovary to FSH + LH
  • due to reduction of follicles
  • increase in anovulatory cycles
  • increased LH + FSH
  • perimenopausal women: hot flushes, urinary incontinence, inc UTIs, irregular vaginal bleeding
  • oestrogen breakthrough bleeding due to lack of progresterone → not maintaining endometrial lining so it breaks down
  • as levels of oestrogen reduces, bleeding gradually ceases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What vasomotor changes occur during menopause?

A
  • 75% experience hot flushes
  • occur with a red flush starting on face + spread down neck + chest
  • associated w/ peripheral vasodilatation + transient rise in body temp
  • due to pulsatile LH release influencing central temp control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What urogenital changes occur during menopause?

A
  • uterus + vagina are both maintained by circulating oestrogen
  • after menopause, marked atrophy of vagina + thinning of myometrium
  • also thinning of vaginal wall and dryness
  • results in dyspareunia
  • bladder + urethra atropy → urinary incontinence + UTIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to bone density during menopause?

A
  • oestrogen protects bone mass + density through reducing activity of osteoclasts
  • with drop in oestrogen → inc bone reabsorption → acceleration of age-related loss of bone density
  • increased frequency in fractures esp wrist and hip
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the link between ischaemic heart disease and menopause?

A
  • oestrogen offers protection against heart disease
  • oestrogen reduces levels of LDL cholesterol whilst raising HDL cholesterol
  • after menopause women exp same freq of CV disease as men
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Summarise the clinical features of the menopause

A
  • change in length of menstrual cycles
  • dysfunctional uterine bleeding
  • hot flushes
  • night sweats
  • vaginal dryness + atrophy
  • urinary frequency
  • anxiety + depression
  • short-term memory impairment
  • osteoporosis
  • inc risk of IHD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is menopause diagnosed?

A
  • when woman has had amenorrhoea for 12 months
  • if menopause occurs between 40-45 → ‘early menopause’
  • measure blood FSH → >40 iu/L indicative of menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 3 categories of managing menopause?

A
  • Lifestyle modifications
  • Hormone replacement therapy
  • Non-hormone replacement therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the management with lifestyle modifications?

A
  • Hot flushes → regular exercise, weight loss + reduce stress
  • Sleep disturbance → avoid late evening exercises + maintaining good sleep hygeine
  • Mood → sleep, regular exercise, relaxation
  • Cognitive → regular exercise + good sleep hygeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the main indications (menopausal symptoms) for hormone replacement therapy?

A
  • vaginal atrophy
  • vasomotor symptoms
  • early natural or surgical menopause (<45yrs)
  • postmenopausal osteoporosis (but other drugs preferred)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the different types of HRT?

A
  • Oestrogen → for women without uterus / post-hysterectomy
  • Oestrogen + progestogen (for women w/ uterus intact)
    • cyclical HRT → for perimenopausal women + within 1yr of cessation of period
    • continuous
  • Oestrogen + progestogen + androgen preparation (AKA Tibolone) - continuous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the different forms of HRT?

A
  • oral: tablets daily
  • implants: twice yearly on abdomen subcut
  • transdermal: patch (1-2x/week) OR gel (daily)
  • topical: vaginal cream / pessary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are absolute contraindications to HRT?

A
  • existing cardiac disease
  • pregnancy
  • active liver disease
  • breast cancer (prev/current)
  • endometrial cancer (prev/current)
  • undiagnosed vaginal bleeding or breast lump
  • prev personal/FHx of VTE/stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are side-effects of HRT?

A
  • nausea + vomiting
  • abdominal cramps
  • bloating
  • weight changes
  • breast enlargement + tenderness
  • premenstrual like symptoms
  • sodium + fluid retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many women get HRT to treat their menopausal symptoms?

A
  • ~10% of women will have some form of HRT to treat their menopausal symptoms
  • current drive by NICE to increase this number as they have found that women were prev being undertreated due to worries about increased cancer risk
  • if woman has uterus then important not to give unopposed oestrogens as this will inc risk of endometrial cancer
  • therefore, oral or transdermal HRT given
  • if woman does not have uterus then oestrogen alone can be given either orally or in a transdermal patch
17
Q

Women should be advised that the symptoms of menopause typically last for 2-5 years and that treatment with HRT brings certain risks, such as what?

A
  • BREAST CANCER → increased risk w/ all combined HRT although risk from dying from breast cancer not raised; greater risk from moderate alcohol use and smoking; risk returns to normal 5yrs after stopping
  • VTE → slight inc in risk with all forms of oral HRT; no inc risk w/ transdermal HRT
  • CHD → combined HRT may be associated w/ slight increased risk
  • OVARIAN CANCER → v small inc risk w/ all HRT
  • ENDOMETRIAL CANCER → oestrogen-only HRT can inc risk; combined lower risk

https://www.chelwest.nhs.uk/services/womens-health-services/gynaecology-services/menopause-and-pms-clinics/links/HRT-risks-and-benefits.pdf

18
Q

What is the management for menopause with non-HRT?

A
  • vasomotor symptoms → fluoxetine, citalopram, venlafazine
  • vaginal dryness → vaginal lubricant or moisturiser
  • psychological → self-help groups, CBT, antidepressants
  • urogenital:
    • atrophy → vaginal oestrogen
    • dryness → moisturisers + lubricants (can be alongside oestrogens)
19
Q

When is treatment for menopause stopped?

A
  • for vasomotor symptoms, 2-5 years of HRT required w/ regular attempts to discontinue treatment
  • vaginal oestrogen may be required long-term
  • when stopping HRT, important to tell woman that gradually reducing HRT is effective at limiting recurrence only in short-term
  • in long term, there is no difference in symptom control
  • woman should be referred to secondary care if treatment ineffective and ongoing side-effects or unexplained bleeding
20
Q

Premature ovarian failure is defined as the onset of menopausal symptoms and elevated gonadotrophin levels before the age of 40 years. It occurs in around 1 in 100 women.

Causes include idiopathic, chemotherapy, autoimmune and radiation.

What are the features?

A

Similar to those of normal climacteric but actual presenting problem may differ:

  • climacteric symptoms → hot flushes, night sweats
  • infertility
  • secondary amenorrhoea
  • raised FSH, LH levels